| CSFZX | IRGSX | CSFZX / IRGSX | |
| Total Expense Ratio | 0.84 | 1.30 | 65% |
| Annual Report Gross Expense Ratio | 0.84 | 1.46 | 58% |
| Fund Existence | 11 years | 20 years | - |
| Gain YTD | 8.766 | 6.724 | 130% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.12B | 133M | 1,591% |
| Annual Yield % from dividends | 2.77 | 2.36 | 117% |
| Returns for 1 year | 8.15 | 6.30 | 129% |
| Returns for 3 years | 22.10 | 18.81 | 117% |
| Returns for 5 years | 17.39 | 13.49 | 129% |
| Returns for 10 years | 47.29 | 20.08 | 236% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JNGLX | 81.78 | 0.41 | +0.50% |
| Janus Henderson Global Life Sciences D | |||
| SUSYX | 13.32 | 0.05 | +0.38% |
| SEI US Managed Volatility Y (SIMT) | |||
| VSFRX | 24.74 | 0.09 | +0.37% |
| Federated Hermes MDT Small Cap Value R | |||
| SXPCX | 54.47 | 0.17 | +0.31% |
| DWS S&P 500 Index C | |||
| SGPSX | 85.67 | N/A | N/A |
| ProFunds Small Cap Growth Svc | |||